A citation-based method for searching scientific literature

Michael Weller, Nicholas Butowski, David D Tran, Lawrence D Recht, Michael Lim, Hal Hirte, Lynn Ashby, Laszlo Mechtler, Samuel A Goldlust, Fabio Iwamoto, Jan Drappatz, Donald M O'Rourke, Mark Wong, Mark G Hamilton, Gaetano Finocchiaro, James Perry, Wolfgang Wick, Jennifer Green, Yi He, Christopher D Turner, Michael J Yellin, Tibor Keler, Thomas A Davis, Roger Stupp, John H Sampson. Lancet Oncol 2017
Times Cited: 396







List of co-cited articles
1438 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Tetanus toxoid and CCL3 improve dendritic cell vaccines in mice and glioblastoma patients.
Duane A Mitchell, Kristen A Batich, Michael D Gunn, Min-Nung Huang, Luis Sanchez-Perez, Smita K Nair, Kendra L Congdon, Elizabeth A Reap, Gary E Archer, Annick Desjardins,[...]. Nature 2015
276
6

EANO guidelines on the diagnosis and treatment of diffuse gliomas of adulthood.
Michael Weller, Martin van den Bent, Matthias Preusser, Emilie Le Rhun, Jörg C Tonn, Giuseppe Minniti, Martin Bendszus, Carmen Balana, Olivier Chinot, Linda Dirven,[...]. Nat Rev Clin Oncol 2021
72
8

CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2013-2017.
Quinn T Ostrom, Nirav Patil, Gino Cioffi, Kristin Waite, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2020
159
6

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.
Eric A Reits, James W Hodge, Carla A Herberts, Tom A Groothuis, Mala Chakraborty, Elizabeth K Wansley, Kevin Camphausen, Rosalie M Luiten, Arnold H de Ru, Joost Neijssen,[...]. J Exp Med 2006
952
5

An immunogenic personal neoantigen vaccine for patients with melanoma.
Patrick A Ott, Zhuting Hu, Derin B Keskin, Sachet A Shukla, Jing Sun, David J Bozym, Wandi Zhang, Adrienne Luoma, Anita Giobbie-Hurder, Lauren Peter,[...]. Nature 2017
5

Microglial stimulation of glioblastoma invasion involves epidermal growth factor receptor (EGFR) and colony stimulating factor 1 receptor (CSF-1R) signaling.
Salvatore J Coniglio, Eliseo Eugenin, Kostantin Dobrenis, E Richard Stanley, Brian L West, Marc H Symons, Jeffrey E Segall. Mol Med 2012
221
5

Audencel Immunotherapy Based on Dendritic Cells Has No Effect on Overall and Progression-Free Survival in Newly Diagnosed Glioblastoma: A Phase II Randomized Trial.
Johanna Buchroithner, Friedrich Erhart, Josef Pichler, Georg Widhalm, Matthias Preusser, Günther Stockhammer, Martha Nowosielski, Sarah Iglseder, Christian F Freyschlag, Stefan Oberndorfer,[...]. Cancers (Basel) 2018
20
25

A randomized phase II study of everolimus in combination with chemoradiation in newly diagnosed glioblastoma: results of NRG Oncology RTOG 0913.
Prakash Chinnaiyan, Minhee Won, Patrick Y Wen, Amyn M Rojiani, Maria Werner-Wasik, Helen A Shih, Lynn S Ashby, Hsiang-Hsuan Michael Yu, Volker W Stieber, Shawn C Malone,[...]. Neuro Oncol 2018
55
9

Two cilengitide regimens in combination with standard treatment for patients with newly diagnosed glioblastoma and unmethylated MGMT gene promoter: results of the open-label, controlled, randomized phase II CORE study.
L Burt Nabors, Karen L Fink, Tom Mikkelsen, Danica Grujicic, Rafal Tarnawski, Do Hyun Nam, Maria Mazurkiewicz, Michael Salacz, Lynn Ashby, Vittorina Zagonel,[...]. Neuro Oncol 2015
128
5


An integrated genomic analysis of human glioblastoma multiforme.
D Williams Parsons, Siân Jones, Xiaosong Zhang, Jimmy Cheng-Ho Lin, Rebecca J Leary, Philipp Angenendt, Parminder Mankoo, Hannah Carter, I-Mei Siu, Gary L Gallia,[...]. Science 2008
5

Response Assessment in Neuro-Oncology Clinical Trials.
Patrick Y Wen, Susan M Chang, Martin J Van den Bent, Michael A Vogelbaum, David R Macdonald, Eudocia Q Lee. J Clin Oncol 2017
122
5

Phase II Study of Radiotherapy and Temsirolimus versus Radiochemotherapy with Temozolomide in Patients with Newly Diagnosed Glioblastoma without MGMT Promoter Hypermethylation (EORTC 26082).
Wolfgang Wick, Thierry Gorlia, Pierre Bady, Michael Platten, Martin J van den Bent, Martin J B Taphoorn, Jonathan Steuve, Alba A Brandes, Marie-France Hamou, Antje Wick,[...]. Clin Cancer Res 2016
67
7

T-cell Dysfunction in Glioblastoma: Applying a New Framework.
Karolina I Woroniecka, Kristen E Rhodin, Pakawat Chongsathidkiet, Kristin A Keith, Peter E Fecci. Clin Cancer Res 2018
82
6

The Neurologic Assessment in Neuro-Oncology (NANO) scale: a tool to assess neurologic function for integration into the Response Assessment in Neuro-Oncology (RANO) criteria.
Lakshmi Nayak, Lisa M DeAngelis, Alba A Brandes, David M Peereboom, Evanthia Galanis, Nancy U Lin, Riccardo Soffietti, David R Macdonald, Marc Chamberlain, James Perry,[...]. Neuro Oncol 2017
66
7

Adoptive Cell Therapy: A Novel and Potential Immunotherapy for Glioblastoma.
Jingyu Wang, Fang Shen, Ying Yao, Lin-Lin Wang, Yongjian Zhu, Jue Hu. Front Oncol 2020
10
50

Immunophenotyping of Newly Diagnosed and Recurrent Glioblastoma Defines Distinct Immune Exhaustion Profiles in Peripheral and Tumor-infiltrating Lymphocytes.
Malte Mohme, Simon Schliffke, Cecile L Maire, Alessandra Rünger, Laura Glau, Klaus C Mende, Jakob Matschke, Christina Gehbauer, Nuray Akyüz, Svenja Zapf,[...]. Clin Cancer Res 2018
62
8

Locoregionally administered B7-H3-targeted CAR T cells for treatment of atypical teratoid/rhabdoid tumors.
Johanna Theruvath, Elena Sotillo, Christopher W Mount, Claus Moritz Graef, Alberto Delaidelli, Sabine Heitzeneder, Louai Labanieh, Shaurya Dhingra, Amaury Leruste, Robbie G Majzner,[...]. Nat Med 2020
41
12

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer.
Naiyer A Rizvi, Matthew D Hellmann, Alexandra Snyder, Pia Kvistborg, Vladimir Makarov, Jonathan J Havel, William Lee, Jianda Yuan, Phillip Wong, Teresa S Ho,[...]. Science 2015
5

Temozolomide versus standard 6-week radiotherapy versus hypofractionated radiotherapy in patients older than 60 years with glioblastoma: the Nordic randomised, phase 3 trial.
Annika Malmström, Bjørn Henning Grønberg, Christine Marosi, Roger Stupp, Didier Frappaz, Henrik Schultz, Ufuk Abacioglu, Björn Tavelin, Benoit Lhermitte, Monika E Hegi,[...]. Lancet Oncol 2012
679
5

Temozolomide chemotherapy alone versus radiotherapy alone for malignant astrocytoma in the elderly: the NOA-08 randomised, phase 3 trial.
Wolfgang Wick, Michael Platten, Christoph Meisner, Jörg Felsberg, Ghazaleh Tabatabai, Matthias Simon, Guido Nikkhah, Kirsten Papsdorf, Joachim P Steinbach, Michael Sabel,[...]. Lancet Oncol 2012
661
5

A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma.
Manfred Westphal, Dana C Hilt, Enoch Bortey, Patrick Delavault, Robert Olivares, Peter C Warnke, Ian R Whittle, Juha Jääskeläinen, Zvi Ram. Neuro Oncol 2003
833
5

Phase II study of cediranib, an oral pan-vascular endothelial growth factor receptor tyrosine kinase inhibitor, in patients with recurrent glioblastoma.
Tracy T Batchelor, Dan G Duda, Emmanuelle di Tomaso, Marek Ancukiewicz, Scott R Plotkin, Elizabeth Gerstner, April F Eichler, Jan Drappatz, Fred H Hochberg, Thomas Benner,[...]. J Clin Oncol 2010
367
5

Adaptive Global Innovative Learning Environment for Glioblastoma: GBM AGILE.
Brian M Alexander, Sujuan Ba, Mitchel S Berger, Donald A Berry, Webster K Cavenee, Susan M Chang, Timothy F Cloughesy, Tao Jiang, Mustafa Khasraw, Wenbin Li,[...]. Clin Cancer Res 2018
67
7

Individualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT): A Bayesian Adaptive Platform Trial to Develop Precision Medicines for Patients With Glioblastoma.
Brian M Alexander, Lorenzo Trippa, Sarah Gaffey, Isabel C Arrillaga-Romany, Eudocia Q Lee, Mikael L Rinne, Manmeet S Ahluwalia, Howard Colman, Geoffrey Fell, Evanthia Galanis,[...]. JCO Precis Oncol 2019
15
33

Treatment of Glioblastoma (GBM) with the Addition of Tumor-Treating Fields (TTF): A Review.
Denise Fabian, Maria Del Pilar Guillermo Prieto Eibl, Iyad Alnahhas, Nikhil Sebastian, Pierre Giglio, Vinay Puduvalli, Javier Gonzalez, Joshua D Palmer. Cancers (Basel) 2019
53
9

Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
Gentao Liu, Xiangpeng Yuan, Zhaohui Zeng, Patrizia Tunici, Hiushan Ng, Iman R Abdulkadir, Lizhi Lu, Dwain Irvin, Keith L Black, John S Yu. Mol Cancer 2006
5

Cellular and Molecular Identity of Tumor-Associated Macrophages in Glioblastoma.
Zhihong Chen, Xi Feng, Cameron J Herting, Virginia Alvarez Garcia, Kai Nie, Winnie W Pong, Rikke Rasmussen, Bhakti Dwivedi, Sandra Seby, Susanne A Wolf,[...]. Cancer Res 2017
223
5

Clinical study of a survivin long peptide vaccine (SurVaxM) in patients with recurrent malignant glioma.
Robert A Fenstermaker, Michael J Ciesielski, Jingxin Qiu, Nuo Yang, Cheryl L Frank, Kelvin P Lee, Laszlo R Mechtler, Ahmed Belal, Manmeet S Ahluwalia, Alan D Hutson. Cancer Immunol Immunother 2016
58
8

A Patient-Derived Glioblastoma Organoid Model and Biobank Recapitulates Inter- and Intra-tumoral Heterogeneity.
Fadi Jacob, Ryan D Salinas, Daniel Y Zhang, Phuong T T Nguyen, Jordan G Schnoll, Samuel Zheng Hao Wong, Radhika Thokala, Saad Sheikh, Deeksha Saxena, Stefan Prokop,[...]. Cell 2020
165
5

A phase I/II trial of pazopanib in combination with lapatinib in adult patients with relapsed malignant glioma.
David A Reardon, Morris D Groves, Patrick Y Wen, Louis Nabors, Tom Mikkelsen, Steve Rosenfeld, Jeffrey Raizer, Jorge Barriuso, Roger E McLendon, A Benjamin Suttle,[...]. Clin Cancer Res 2013
64
7

RTOG 0211: a phase 1/2 study of radiation therapy with concurrent gefitinib for newly diagnosed glioblastoma patients.
Arnab Chakravarti, Meihua Wang, H Ian Robins, Tim Lautenschlaeger, Walter J Curran, David G Brachman, Christopher J Schultz, Ali Choucair, Marisa Dolled-Filhart, Jason Christiansen,[...]. Int J Radiat Oncol Biol Phys 2013
84
5

Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma.
Frank B Furnari, Timothy F Cloughesy, Webster K Cavenee, Paul S Mischel. Nat Rev Cancer 2015
194
5

The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas.
Daniela F Quail, Robert L Bowman, Leila Akkari, Marsha L Quick, Alberto J Schuhmacher, Jason T Huse, Eric C Holland, James C Sutton, Johanna A Joyce. Science 2016
280
5

An Integrative Model of Cellular States, Plasticity, and Genetics for Glioblastoma.
Cyril Neftel, Julie Laffy, Mariella G Filbin, Toshiro Hara, Marni E Shore, Gilbert J Rahme, Alyssa R Richman, Dana Silverbush, McKenzie L Shaw, Christine M Hebert,[...]. Cell 2019
357
5

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma.
Rossella Galli, Elena Binda, Ugo Orfanelli, Barbara Cipelletti, Angela Gritti, Simona De Vitis, Roberta Fiocco, Chiara Foroni, Francesco Dimeco, Angelo Vescovi. Cancer Res 2004
5

Glioblastoma: Overview of Disease and Treatment.
Mary Elizabeth Davis. Clin J Oncol Nurs 2016
345
5

PD-L1/PD-1 Axis in Glioblastoma Multiforme.
Jakub Litak, Marek Mazurek, Cezary Grochowski, Piotr Kamieniak, Jacek Roliński. Int J Mol Sci 2019
38
13

Phase III randomized trial of CED of IL13-PE38QQR vs Gliadel wafers for recurrent glioblastoma.
Sandeep Kunwar, Susan Chang, Manfred Westphal, Michael Vogelbaum, John Sampson, Gene Barnett, Mark Shaffrey, Zvi Ram, Joseph Piepmeier, Michael Prados,[...]. Neuro Oncol 2010
274
5

Tumor-associated microglia/macrophages enhance the invasion of glioma stem-like cells via TGF-β1 signaling pathway.
Xian-zong Ye, Sen-lin Xu, Yan-hong Xin, Shi-cang Yu, Yi-fang Ping, Lu Chen, Hua-liang Xiao, Bin Wang, Liang Yi, Qing-liang Wang,[...]. J Immunol 2012
250
5

Novel and shared neoantigen derived from histone 3 variant H3.3K27M mutation for glioma T cell therapy.
Zinal S Chheda, Gary Kohanbash, Kaori Okada, Naznin Jahan, John Sidney, Matteo Pecoraro, Xinbo Yang, Diego A Carrera, Kira M Downey, Shruti Shrivastav,[...]. J Exp Med 2018
105
5

Mutational analysis reveals the origin and therapy-driven evolution of recurrent glioma.
Brett E Johnson, Tali Mazor, Chibo Hong, Michael Barnes, Koki Aihara, Cory Y McLean, Shaun D Fouse, Shogo Yamamoto, Hiroki Ueda, Kenji Tatsuno,[...]. Science 2014
778
5

A dural lymphatic vascular system that drains brain interstitial fluid and macromolecules.
Aleksanteri Aspelund, Salli Antila, Steven T Proulx, Tine Veronica Karlsen, Sinem Karaman, Michael Detmar, Helge Wiig, Kari Alitalo. J Exp Med 2015
831
5

Immune microenvironment of gliomas.
Anna Gieryng, Dominika Pszczolkowska, Kacper A Walentynowicz, Wenson D Rajan, Bozena Kaminska. Lab Invest 2017
156
5

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma.
Robert H I Andtbacka, Howard L Kaufman, Frances Collichio, Thomas Amatruda, Neil Senzer, Jason Chesney, Keith A Delman, Lynn E Spitler, Igor Puzanov, Sanjiv S Agarwala,[...]. J Clin Oncol 2015
5

CBTRUS Statistical Report: Primary Brain and Central Nervous System Tumors Diagnosed in the United States in 2008-2012.
Quinn T Ostrom, Haley Gittleman, Jordonna Fulop, Max Liu, Rachel Blanda, Courtney Kromer, Yingli Wolinsky, Carol Kruchko, Jill S Barnholtz-Sloan. Neuro Oncol 2015
5

ErbB2/HER2-Specific NK Cells for Targeted Therapy of Glioblastoma.
Congcong Zhang, Michael C Burger, Lukas Jennewein, Sabrina Genßler, Kurt Schönfeld, Pia Zeiner, Elke Hattingen, Patrick N Harter, Michel Mittelbronn, Torsten Tonn,[...]. J Natl Cancer Inst 2015
141
5

CAR-Engineered NK Cells Targeting Wild-Type EGFR and EGFRvIII Enhance Killing of Glioblastoma and Patient-Derived Glioblastoma Stem Cells.
Jianfeng Han, Jianhong Chu, Wing Keung Chan, Jianying Zhang, Youwei Wang, Justus B Cohen, Aaron Victor, Walter H Meisen, Sung-Hak Kim, Paola Grandi,[...]. Sci Rep 2015
161
5

Dendritic cell vaccination in glioblastoma patients induces systemic and intracranial T-cell responses modulated by the local central nervous system tumor microenvironment.
Linda M Liau, Robert M Prins, Sylvia M Kiertscher, Sylvia K Odesa, Thomas J Kremen, Adrian J Giovannone, Jia-Wei Lin, Dennis J Chute, Paul S Mischel, Timothy F Cloughesy,[...]. Clin Cancer Res 2005
374
5

Glioblastoma stem cells: lessons from the tumor hierarchy in a lethal cancer.
Ryan C Gimple, Shruti Bhargava, Deobrat Dixit, Jeremy N Rich. Genes Dev 2019
89
5


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.